Operating Lease, Right-of-Use Asset of OCULAR THERAPEUTIX, INC from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
OCULAR THERAPEUTIX, INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • OCULAR THERAPEUTIX, INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5,334,000, a 6.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

OCULAR THERAPEUTIX, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,334,000 -$360,000 -6.3% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $5,883,000 -$122,000 -2% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $5,828,000 -$231,000 -3.8% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $5,945,000 -$527,000 -8.1% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $5,694,000 -$1,174,000 -17% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $6,005,000 -$1,247,000 -17% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $6,059,000 -$1,566,000 -21% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $6,472,000 -$1,570,000 -20% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $6,868,000 +$2,864,000 +72% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $7,252,000 +$2,947,000 +68% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $7,625,000 +$3,033,000 +66% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $8,042,000 +$3,175,000 +65% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 $4,004,000 -$1,125,000 -22% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $4,305,000 -$1,073,000 -20% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $4,592,000 -$1,025,000 -18% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $4,867,000 -$977,000 -17% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $5,129,000 -$933,000 -15% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $5,378,000 -$891,000 -14% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $5,617,000 -$850,000 -13% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $5,844,000 -$811,000 -12% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $6,062,000 -$774,000 -11% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $6,269,000 -$741,000 -11% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $6,467,000 +$1,311,000 +25% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $6,655,000 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $6,836,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $7,010,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $5,156,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.